{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:17:39Z","timestamp":1792275459681,"version":"4.4.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-023-02747-7","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T15:05:01Z","timestamp":1702998301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Sebaceous carcinoma: an updated review of pathogenesis, diagnosis, and treatment options"],"prefix":"10.1007","volume":"316","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8976-4204","authenticated-orcid":false,"given":"Caitlin","family":"Dowell-Esquivel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1246-2806","authenticated-orcid":false,"given":"Raphael","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7639-2512","authenticated-orcid":false,"suffix":"III","given":"Robert C.","family":"DiCaprio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyvan","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"issue":"6","key":"2747_CR1","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.jaad.2016.07.046","volume":"75","author":"R Tripathi","year":"2016","unstructured":"Tripathi R et al (2016) Incidence and survival of sebaceous carcinoma in the United States. J Am Acad Dermatol 75(6):1210\u20131215","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2747_CR2","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s10792-018-0925-z","volume":"39","author":"MV Cicinelli","year":"2019","unstructured":"Cicinelli MV, Kaliki S (2019) Ocular sebaceous gland carcinoma: an update of the literature. Int Ophthalmol 39(5):1187\u20131197","journal-title":"Int Ophthalmol"},{"issue":"12","key":"2747_CR3","doi-asserted-by":"publisher","first-page":"e699","DOI":"10.1016\/S1470-2045(19)30673-4","volume":"20","author":"JL Owen","year":"2019","unstructured":"Owen JL et al (2019) Sebaceous carcinoma: evidence-based clinical practice guidelines. Lancet Oncol 20(12):e699\u2013e714","journal-title":"Lancet Oncol"},{"issue":"4","key":"2747_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/IOP.0000000000001863","volume":"37","author":"S Kaliki","year":"2021","unstructured":"Kaliki S et al (2021) Sebaceous gland carcinoma: influence of age at presentation on outcomes. Ophthalmic Plast Reconstr Surg 37(4):341\u2013345","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"2747_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/DSS.0000000000002660","volume":"47","author":"VM Desiato","year":"2021","unstructured":"Desiato VM et al (2021) Sebaceous carcinoma of the eyelid: a systematic review and meta-analysis. Dermatol Surg 47(1):104\u2013110","journal-title":"Dermatol Surg"},{"issue":"11","key":"2747_CR6","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1111\/1346-8138.13905","volume":"44","author":"H Satomura","year":"2017","unstructured":"Satomura H et al (2017) Dermoscopic features of ocular and extraocular sebaceous carcinomas. J Dermatol 44(11):1313\u20131316","journal-title":"J Dermatol"},{"issue":"10","key":"2747_CR7","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.3390\/diagnostics13101676","volume":"13","author":"I Papadimitriou","year":"2023","unstructured":"Papadimitriou I et al (2023) Sebaceous neoplasms. Diagnostics (Basel) 13(10):1676","journal-title":"Diagnostics (Basel)"},{"issue":"7","key":"2747_CR8","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/1346-8138.15384","volume":"47","author":"CY Cheng","year":"2020","unstructured":"Cheng CY, Su HJ, Kuo TT (2020) Dermoscopic features and differential diagnosis of sebaceous carcinoma. J Dermatol 47(7):755\u2013762","journal-title":"J Dermatol"},{"issue":"3","key":"2747_CR9","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.1111\/ajd.13234","volume":"61","author":"A Wu","year":"2020","unstructured":"Wu A et al (2020) Cutaneous sebaceous carcinoma. Austral J Dermatol 61(3):e283\u2013e292","journal-title":"Austral J Dermatol"},{"issue":"12","key":"2747_CR10","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.ophtha.2004.07.031","volume":"111","author":"JA Shields","year":"2004","unstructured":"Shields JA et al (2004) Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology 111(12):2151\u20132157","journal-title":"Ophthalmology"},{"issue":"12","key":"2747_CR11","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/jamadermatol.2014.1217","volume":"150","author":"JN Everett","year":"2014","unstructured":"Everett JN et al (2014) Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm. JAMA Dermatol 150(12):1315\u20131321","journal-title":"JAMA Dermatol"},{"issue":"5","key":"2747_CR12","first-page":"1784","volume":"6","author":"MM Entius","year":"2000","unstructured":"Entius MM et al (2000) Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin Cancer Res 6(5):1784\u20131789","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2747_CR13","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/gim.2014.19","volume":"16","author":"ME Roberts","year":"2014","unstructured":"Roberts ME et al (2014) A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome. Genet Med 16(9):711\u2013716","journal-title":"Genet Med"},{"issue":"2","key":"2747_CR14","doi-asserted-by":"publisher","first-page":"pkaa020","DOI":"10.1093\/jncics\/pkaa020","volume":"4","author":"MR Sargen","year":"2020","unstructured":"Sargen MR et al (2020) Ambient ultraviolet radiation and sebaceous carcinoma incidence in the United States, 2000\u20132016. JNCI Cancer Spectr 4(2):pkaa020","journal-title":"JNCI Cancer Spectr"},{"issue":"8","key":"2747_CR15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/DSS.0000000000003506","volume":"48","author":"F Wang","year":"2022","unstructured":"Wang F, Wang XY, Jiang X (2022) Clinical features and prognosis of young and middle-aged adults with skin sebaceous adenocarcinoma. Dermatol Surg 48(8):797\u2013801","journal-title":"Dermatol Surg"},{"issue":"6","key":"2747_CR16","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0161-6420(01)00555-3","volume":"108","author":"T Kivel\u00e4","year":"2001","unstructured":"Kivel\u00e4 T et al (2001) Sebaceous carcinoma of the eyelid associated with retinoblastoma. Ophthalmology 108(6):1124\u20131128","journal-title":"Ophthalmology"},{"issue":"12","key":"2747_CR17","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/archopht.116.12.1670","volume":"116","author":"S Rumelt","year":"1998","unstructured":"Rumelt S et al (1998) Four-eyelid sebaceous cell carcinoma following irradiation. Arch Ophthalmol 116(12):1670\u20131672","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"2747_CR18","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jamadermatol.2020.3111","volume":"156","author":"MR Sargen","year":"2020","unstructured":"Sargen MR et al (2020) Sebaceous carcinoma incidence and survival among solid organ transplant recipients in the United States, 1987\u20132017. JAMA Dermatol 156(12):1307\u20131314","journal-title":"JAMA Dermatol"},{"issue":"7","key":"2747_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.0303-6987.2005.00371.x","volume":"32","author":"PR Pereira","year":"2005","unstructured":"Pereira PR et al (2005) Histopathological review of sebaceous carcinoma of the eyelid. J Cutan Pathol 32(7):496\u2013501","journal-title":"J Cutan Pathol"},{"issue":"1","key":"2747_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/sj.eye.6700523","volume":"18","author":"MM Muqit","year":"2004","unstructured":"Muqit MM et al (2004) Improved survival rates in sebaceous carcinoma of the eyelid. Eye (Lond) 18(1):49\u201353","journal-title":"Eye (Lond)"},{"issue":"6","key":"2747_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/01.dad.0000245200.65600.a4","volume":"28","author":"ES Cabral","year":"2006","unstructured":"Cabral ES et al (2006) Distinction of benign sebaceous proliferations from sebaceous carcinomas by immunohistochemistry. Am J Dermatopathol 28(6):465\u2013471","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"2747_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ajo.2013.08.015","volume":"157","author":"FA Jakobiec","year":"2014","unstructured":"Jakobiec FA, Mendoza PR (2014) Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin. Am J Ophthalmol 157(1):186-208.e2","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"2747_CR23","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jcjo.2014.04.004","volume":"49","author":"K Mulay","year":"2014","unstructured":"Mulay K et al (2014) Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor). Can J Ophthalmol 49(4):326\u2013332","journal-title":"Can J Ophthalmol"},{"issue":"6","key":"2747_CR24","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/DAD.0b013e31820a2027","volume":"33","author":"S Ansai","year":"2011","unstructured":"Ansai S et al (2011) Sebaceous carcinoma: an immunohistochemical reappraisal. Am J Dermatopathol 33(6):579\u2013587","journal-title":"Am J Dermatopathol"},{"issue":"11","key":"2747_CR25","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1097\/DAD.0000000000000255","volume":"37","author":"JA Plaza","year":"2015","unstructured":"Plaza JA et al (2015) Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study. Am J Dermatopathol 37(11):809\u2013821","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"2747_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.anndiagpath.2015.07.002","volume":"19","author":"K Behzato\u011flu","year":"2015","unstructured":"Behzato\u011flu K (2015) Urothelial Carcinoma with shadow cell, lipid cell and sebaceous (skin adnexal) differentiation: clinicopathological and immunohistochemical study of 10 cases. Ann Diagn Pathol 19(5):314\u2013319","journal-title":"Ann Diagn Pathol"},{"key":"2747_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/CMAR.S392573","volume":"15","author":"W Ju","year":"2023","unstructured":"Ju W et al (2023) Sebaceous carcinoma of the submandibular gland a case report and review of the literature. Cancer Manage Res 15:123\u2013130","journal-title":"Cancer Manage Res"},{"issue":"1","key":"2747_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/IOP.0000000000001133","volume":"35","author":"S Ding","year":"2019","unstructured":"Ding S et al (2019) Change in eyelid carcinoma T category with use of the 8th versus 7th edition of the American Joint Committee on Cancer: cancer staging manual. Ophthalmic Plast Reconstr Surg 35(1):38\u201341","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"6","key":"2747_CR29","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s41433-019-0454-7","volume":"33","author":"Y Hsia","year":"2019","unstructured":"Hsia Y et al (2019) Eyelid sebaceous carcinoma: validation of the 8th edition of the American Joint Committee on cancer T staging system and the prognostic factors for local recurrence, nodal metastasis, and survival. Eye 33(6):887\u2013895","journal-title":"Eye"},{"issue":"7","key":"2747_CR30","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1136\/bjophthalmol-2018-312635","volume":"103","author":"HS Sa","year":"2019","unstructured":"Sa HS et al (2019) Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients. Br J Ophthalmol 103(7):980\u2013984","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"2747_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/01.IOP.0000152494.47038.0E","volume":"21","author":"JA Shields","year":"2005","unstructured":"Shields JA et al (2005) Conjunctival epithelial involvement by eyelid sebaceous carcinoma. The 2003 J. Howard Stokes lecture. Ophthalmic Plast Reconstr Surg 21(2):92\u201396","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"2747_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0161-6420(92)31988-8","volume":"99","author":"CE Margo","year":"1992","unstructured":"Margo CE, Lessner A, Stern GA (1992) Intraepithelial sebaceous carcinoma of the conjunctiva and skin of the eyelid. Ophthalmology 99(2):227\u2013231","journal-title":"Ophthalmology"},{"issue":"5","key":"2747_CR33","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/IOP.0b013e3182163653","volume":"27","author":"M Connor","year":"2011","unstructured":"Connor M et al (2011) Management of perineural invasion in sebaceous carcinoma of the eyelid. Ophthalmic Plast Reconstr Surg 27(5):356\u2013359","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"3","key":"2747_CR34","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3109\/01676830.2011.648799","volume":"31","author":"SV Deo","year":"2012","unstructured":"Deo SV et al (2012) Locally advanced sebaceous cell carcinoma (T3) of eyelid: incidence and pattern of nodal metastases and combined modality management approach. Orbit 31(3):150\u2013154","journal-title":"Orbit"},{"issue":"1","key":"2747_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40792-017-0346-7","volume":"3","author":"Y Ishiguro","year":"2017","unstructured":"Ishiguro Y et al (2017) Usefulness of PET\/CT for early detection of internal malignancies in patients with Muir-Torre syndrome: report of two cases. Surg Case Rep 3(1):71","journal-title":"Surg Case Rep"},{"issue":"5","key":"2747_CR36","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00417-006-0497-x","volume":"245","author":"SM Krishna","year":"2007","unstructured":"Krishna SM et al (2007) 18-FDG PET\/CT staging of ocular sebaceous cell carcinoma. Graefes Arch Clin Exp Ophthalmol 245(5):759\u2013760","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"2747_CR37","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jaad.2022.07.015","volume":"88","author":"NJ Maloney","year":"2023","unstructured":"Maloney NJ et al (2023) Yield of sentinel lymph node biopsy in sebaceous carcinoma and predictors of advanced disease: a retrospective analysis of the National Cancer Database. J Am Acad Dermatol 88(2):504\u2013506","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"2747_CR38","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1001\/archotol.133.8.820","volume":"133","author":"VH Ho","year":"2007","unstructured":"Ho VH et al (2007) Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Arch Otolaryngol Head Neck Surg 133(8):820\u2013826","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"2747_CR39","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1097\/IOP.0b013e3181ef7450","volume":"27","author":"A Savar","year":"2011","unstructured":"Savar A et al (2011) Positive sentinel node in sebaceous carcinoma of the eyelid. Ophthalmic Plast Reconstr Surg 27(1):e4\u2013e6","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2747_CR40","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ebiom.2018.09.011","volume":"36","author":"C Zhou","year":"2018","unstructured":"Zhou C et al (2018) Contemporary update of overall prognosis and nomogram to predict individualized survival for Chinese patients with eyelid sebaceous carcinoma. EBioMedicine 36:221\u2013228","journal-title":"EBioMedicine"},{"issue":"2","key":"2747_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0046-8177(82)80115-9","volume":"13","author":"NA Rao","year":"1982","unstructured":"Rao NA et al (1982) Sebaceous carcinomas of the ocular adnexa: a clinicopathologic study of 104 cases, with five-year follow-up data. Hum Pathol 13(2):113\u2013122","journal-title":"Hum Pathol"},{"issue":"1","key":"2747_CR42","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000310872","volume":"211","author":"M Dogru","year":"1997","unstructured":"Dogru M et al (1997) Management of eyelid sebaceous carcinomas. Ophthalmologica 211(1):40\u201343","journal-title":"Ophthalmologica"},{"issue":"2","key":"2747_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0007-1226(91)90044-K","volume":"44","author":"KC Tan","year":"1991","unstructured":"Tan KC, Lee ST, Cheah ST (1991) Surgical treatment of sebaceous carcinoma of eyelids with clinico-pathological correlation. Br J Plast Surg 44(2):117\u2013121","journal-title":"Br J Plast Surg"},{"issue":"2","key":"2747_CR44","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0733-8635(18)30756-3","volume":"5","author":"RG Bennett","year":"1987","unstructured":"Bennett RG (1987) Mohs\u2019 surgery. New concepts and applications. Dermatol Clin 5(2):409\u2013428","journal-title":"Dermatol Clin"},{"issue":"2","key":"2747_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.det.2011.01.010","volume":"29","author":"LB Trost","year":"2011","unstructured":"Trost LB, Bailin PL (2011) History of Mohs surgery. Dermatol Clin 29(2):135\u2013139","journal-title":"Dermatol Clin"},{"issue":"10","key":"2747_CR46","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1111\/j.1524-4725.2012.02574.x","volume":"38","author":"SM Connolly","year":"2012","unstructured":"Connolly SM et al (2012) AAD\/ACMS\/ASDSA\/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. Dermatol Surg 38(10):1582\u20131603","journal-title":"Dermatol Surg"},{"issue":"6","key":"2747_CR47","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1067\/mjd.2001.113692","volume":"44","author":"JM Spencer","year":"2001","unstructured":"Spencer JM et al (2001) Sebaceous carcinoma of the eyelid treated with Mohs micrographic surgery. J Am Acad Dermatol 44(6):1004\u20131009","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2747_CR48","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.jaad.2018.12.053","volume":"80","author":"C Zhou","year":"2019","unstructured":"Zhou C et al (2019) Mohs micrographic surgery for eyelid sebaceous carcinoma: a multicenter cohort of 360 patients. J Am Acad Dermatol 80(6):1608-1617.e1","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2747_CR49","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/IOP.0000000000001343","volume":"35","author":"HS Sa","year":"2019","unstructured":"Sa HS, Tetzlaff MT, Esmaeli B (2019) Predictors of local recurrence for eyelid sebaceous carcinoma: questionable value of routine conjunctival map biopsies for detection of pagetoid spread. Ophthalmic Plast Reconstr Surg 35(5):419\u2013425","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"3","key":"2747_CR50","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/0002-9394(74)90738-7","volume":"77","author":"HD Cavanagh","year":"1974","unstructured":"Cavanagh HD, Green WR, Goldberg HK (1974) Multicentric sebaceous adenocarcinoma of the meibomian gland. Am J Ophthalmol 77(3):326\u2013332","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"2747_CR51","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0002-9394(14)74400-9","volume":"103","author":"R Folberg","year":"1987","unstructured":"Folberg R et al (1987) Recurrent and residual sebaceous carcinoma after Mohs\u2019 excision of the primary lesion. Am J Ophthalmol 103(6):817\u2013823","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"2747_CR52","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0002-9394(86)90214-X","volume":"102","author":"AM Putterman","year":"1986","unstructured":"Putterman AM (1986) Conjunctival map biopsy to determine pagetoid spread. Am J Ophthalmol 102(1):87\u201390","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"2747_CR53","first-page":"623","volume":"28","author":"SN Snow","year":"2002","unstructured":"Snow SN et al (2002) Sebaceous carcinoma of the eyelids treated by mohs micrographic surgery: report of nine cases with review of the literature. Dermatol Surg 28(7):623\u2013631","journal-title":"Dermatol Surg"},{"issue":"3","key":"2747_CR54","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/IOP.0b013e31816d925f","volume":"24","author":"A Song","year":"2008","unstructured":"Song A et al (2008) Sebaceous cell carcinoma of the ocular adnexa: clinical presentations, histopathology, and outcomes. Ophthalmic Plast Reconstr Surg 24(3):194\u2013200","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"5","key":"2747_CR55","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00002341-200109000-00010","volume":"17","author":"JA Shields","year":"2001","unstructured":"Shields JA et al (2001) Experience with eyelid-sparing orbital exenteration: the 2000 Tullos O. Coston lecture. Ophthalmic Plast Reconstr Surg 17(5):355\u2013361","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"10","key":"2747_CR56","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/S0161-6420(01)00719-9","volume":"108","author":"AN Chao","year":"2001","unstructured":"Chao AN et al (2001) Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion. Ophthalmology 108(10):1877\u20131883","journal-title":"Ophthalmology"},{"issue":"7","key":"2747_CR57","first-page":"3643","volume":"17","author":"A Belaid","year":"2016","unstructured":"Belaid A et al (2016) Radiation therapy for primary eyelid cancers in Tunisia. Asian Pac J Cancer Prev 17(7):3643\u20133646","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"2747_CR58","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/00002341-200005000-00008","volume":"16","author":"MT Yen","year":"2000","unstructured":"Yen MT et al (2000) Radiation therapy for local control of eyelid sebaceous cell carcinoma: report of two cases and review of the literature. Ophthalmic Plast Reconstr Surg 16(3):211\u2013215","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"2747_CR59","doi-asserted-by":"publisher","first-page":"630","DOI":"10.4103\/ijo.IJO_1814_21","volume":"70","author":"MS Alam","year":"2022","unstructured":"Alam MS, Banerjee P, Krishnakumar S (2022) The effect of direct cell injury inflicted by cryotherapy on eyelid sebaceous gland carcinoma cells: an ex-vivo experimental study. Indian J Ophthalmol 70(2):630\u2013633","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"2747_CR60","doi-asserted-by":"publisher","first-page":"e316","DOI":"10.3747\/co.22.2467","volume":"22","author":"V Kumar","year":"2015","unstructured":"Kumar V, Xu Y (2015) Unusual presentation of metastatic sebaceous carcinoma and its response to chemotherapy: is genotyping a right answer for guiding chemotherapy in rare tumours? Curr Oncol 22(4):e316\u2013e319","journal-title":"Curr Oncol"},{"issue":"10","key":"2747_CR61","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1007\/s00417-013-2382-8","volume":"251","author":"A Gogia","year":"2013","unstructured":"Gogia A et al (2013) Avoidance of exenteration in orbital sebaceous gland carcinoma with neoadjuvant chemotherapy. Graefes Arch Clin Exp Ophthalmol 251(10):2479\u20132480","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"2747_CR62","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/IOP.0000000000000398","volume":"32","author":"S Kaliki","year":"2016","unstructured":"Kaliki S et al (2016) Neoadjuvant systemic chemotherapy in the management of extensive eyelid sebaceous gland carcinoma: a study of 10 cases. Ophthalmic Plast Reconstr Surg 32(1):35\u201339","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"2747_CR63","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40425-018-0357-3","volume":"6","author":"E Domingo-Musibay","year":"2018","unstructured":"Domingo-Musibay E et al (2018) Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma. J Immunother Cancer 6(1):58","journal-title":"J Immunother Cancer"},{"issue":"1","key":"2747_CR64","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1111\/ajco.12088","volume":"12","author":"YH Jung","year":"2016","unstructured":"Jung YH et al (2016) Palliative 5-fluorouracil and cisplatin chemotherapy in recurrent metastatic sebaceous carcinoma: case report and literature review. Asia Pac J Clin Oncol 12(1):e189\u2013e193","journal-title":"Asia Pac J Clin Oncol"},{"issue":"3","key":"2747_CR65","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2147\/OPTH.S1606","volume":"2","author":"JW Kim","year":"2008","unstructured":"Kim JW, Abramson DH (2008) Topical treatment options for conjunctival neoplasms. Clin Ophthalmol 2(3):503\u2013515","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"2747_CR66","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/S0161-6420(02)01239-3","volume":"109","author":"CL Shields","year":"2002","unstructured":"Shields CL et al (2002) Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma. Ophthalmology 109(11):2129\u20132133","journal-title":"Ophthalmology"},{"issue":"4","key":"2747_CR67","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3892\/mco.2016.746","volume":"4","author":"G Della Vittoria Scarpati","year":"2016","unstructured":"Della Vittoria Scarpati G et al (2016) Concomitant cetuximab and radiation therapy: a possible promising strategy for locally advanced inoperable non-melanoma skin carcinomas. Mol Clin Oncol 4(4):467\u2013471","journal-title":"Mol Clin Oncol"},{"issue":"9","key":"2747_CR68","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1038\/s41433-019-0756-9","volume":"34","author":"LA McGrath","year":"2020","unstructured":"McGrath LA et al (2020) Management of recurrent sebaceous gland carcinoma. Eye (Lond) 34(9):1685\u20131692","journal-title":"Eye (Lond)"},{"issue":"1","key":"2747_CR69","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/cncr.23952","volume":"115","author":"T Dasgupta","year":"2009","unstructured":"Dasgupta T, Wilson LD, Yu JB (2009) A retrospective review of 1349 cases of sebaceous carcinoma. Cancer 115(1):158\u2013165","journal-title":"Cancer"},{"issue":"1","key":"2747_CR70","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1365-2133.2004.06047.x","volume":"151","author":"NW Smeets","year":"2004","unstructured":"Smeets NW et al (2004) Mohs\u2019 micrographic surgery for treatment of basal cell carcinoma of the face\u2013results of a retrospective study and review of the literature. Br J Dermatol 151(1):141\u2013147","journal-title":"Br J Dermatol"},{"issue":"2","key":"2747_CR71","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/DSS.0000000000000943","volume":"43","author":"KL Brady","year":"2017","unstructured":"Brady KL, Hurst EA (2017) Sebaceous carcinoma treated with Mohs micrographic surgery. Dermatol Surg 43(2):281\u2013286","journal-title":"Dermatol Surg"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02747-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-023-02747-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02747-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T16:07:02Z","timestamp":1704730022000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-023-02747-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["2747"],"URL":"https:\/\/doi.org\/10.1007\/s00403-023-02747-7","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,19]]},"assertion":[{"value":"30 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"IRB approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval status"}}],"article-number":"55"}}